Survey Reveals American Perceptions of Weight-Loss Drugs and Their Impact on Obesity
A recent Pew Research Center survey reveals Americans’ perceptions of weight-loss drugs like Ozempic and Wegovy, with 53% believing they are viable options for individuals with obesity. Despite high demand and supply shortages, only 16% of respondents expect these drugs to significantly reduce obesity in the U.S.
Prevalence of Nonprescribed Weight-Loss Product Consumption Among Adolescents: 5 Key Takeaways
A recent systematic review and meta-analysis published in JAMA uncovered 5 key takeaways about the prevalence of nonprescribed weight-loss product consumption among adolescents, shedding light on this concerning trend.
UK’s Efforts to Combat Obesity Hit Roadblock as Firms Increase Calorie Content in Food Products
Government’s efforts to combat obesity crisis face a setback as firms increase calorie content in food products, defying calls for reduction. Men and women consuming excess calories, with significant increases in calorie consumption from various product types. Report highlights challenges in reducing calorie intake and underscores the need for more robust strategies and collaboration with food industry stakeholders.
Study Explores Relationship Between Kimchi Consumption and Obesity in South Korea
In a recent study published in the journal BMJ Open, researchers explored the relationship between kimchi consumption and obesity in South Korea. Obesity is associated with nutritional, environmental, and lifestyle factors and is a significant risk factor for diabetes, chronic…
Obesity Drugs’ Superpower: Taming Inflammation
Obesity drugs have another superpower: taming inflammation The latest generation of anti-obesity drugs has taken the world by storm, thanks to their effectiveness at treating diabetes and reducing weight. But these drugs also have a less well-known superpower: the ability…
High Stress Levels from Adolescence to Adulthood Linked to Increased Cardiometabolic Risk, Study Finds
High stress levels from teenage years to adulthood may significantly increase the risk of developing cardiometabolic diseases, according to a recent study published in the Journal of the American Heart Association. The study, conducted by researchers from the Keck School…
Doctor Michael Mosley Advocates for Omega 3 Supplements
Diet and wellbeing guru Doctor Michael Mosley has recently advocated for the use of Omega 3 supplements as a beneficial addition to one’s diet. In a post on his Instagram feed, Dr. Mosley highlighted the potential impact of Omega 3…
Diabetes Drug Shows Promise in Protecting Against Colorectal Cancer
A recent analysis by researchers in the US suggests that a drug commonly used to treat type 2 diabetes could also be effective in protecting against colorectal cancer (CRC). The drug, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), has…
Novo Nordisk and Eli Lilly Expected to Lead Global New Drug Sales in 2024
According to a recent report from Evaluate, Novo Nordisk and Eli Lilly are expected to lead in global new drug sales in 2024. The booming demand for blood sugar-modulating diabetes and obesity drugs has propelled these two companies to dominate…
Tirzepatide vs. Semaglutide: A Comparison
There has been a lot of buzz in the weight loss space with the emergence of medications like tirzepatide and semaglutide. But what’s the deal with tirzepatide vs. semaglutide? Let’s dive into the details. At a basic level, tirzepatide, also…